Tapani Elovirta starts as Commercial Director of Uniogen

Uniogen continues to grow the team and is expanding its portfolio by developing new diagnostic solutions. To support the growth, Tapani Elovirta is taking the position of Commercial Director on November 15. He will lead the company’s commercial team ensuring the growth and profitability of Uniogen’s portfolio.

Tapani has a long and remarkable record in the life science industry. He joins Uniogen from Fapon Biotech Inc., where he held a position of senior sales manager, Europe. He has nearly two decades of experience in the field of in vitro diagnostics sales. Tapani has vast experience in B2B sales as well as building and supporting distribution networks, which makes him an ideal match for Uniogen.

“The Uniogen team has an impressive amount of expertise, and the company has enormous growth potential, which makes the position very interesting,” Tapani says. He defines himself as a team builder and an enabler.

At Uniogen, Tapani will start by developing the company’s marketing strategies and coordinating the marketing and sales team’s initiatives as the merger of Abacus Diagnostica, Labrox and Kaivogen into Uniogen is taking the final steps at the end of 2022.

As his first task Tapani is joining the team at MEDICA 2022 healthcare trade fair on November 14–17 in Düsseldorf. He is looking forward to meeting clients and making new contacts as Uniogen is presenting full portfolio at the fair.

Abacus Diagnostica, Kaivogen and Labrox are now Uniogen

Uniogen is a global pioneer in clinical diagnostics, point-of-care testing, and instrumentation for life sciences.

Uniogen – Enabling diagnosis and care at first appointment